Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach

Abstract Currently, no approved vaccine is available against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes severe respiratory disease. The spike glycoprotein is typically considered a suitable target for MERS-CoV vaccine candidates. A computational strategy can be used to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shafi Mahmud, Md. Oliullah Rafi, Gobindo Kumar Paul, Maria Meha Promi, Mst. Sharmin Sultana Shimu, Suvro Biswas, Talha Bin Emran, Kuldeep Dhama, Salem A. Alyami, Mohammad Ali Moni, Md. Abu Saleh
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a7e3b9f2bf8947859cc3790916ca13fa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a7e3b9f2bf8947859cc3790916ca13fa
record_format dspace
spelling oai:doaj.org-article:a7e3b9f2bf8947859cc3790916ca13fa2021-12-02T16:30:10ZDesigning a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach10.1038/s41598-021-92176-12045-2322https://doaj.org/article/a7e3b9f2bf8947859cc3790916ca13fa2021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92176-1https://doaj.org/toc/2045-2322Abstract Currently, no approved vaccine is available against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes severe respiratory disease. The spike glycoprotein is typically considered a suitable target for MERS-CoV vaccine candidates. A computational strategy can be used to design an antigenic vaccine against a pathogen. Therefore, we used immunoinformatics and computational approaches to design a multi-epitope vaccine that targets the spike glycoprotein of MERS-CoV. After using numerous immunoinformatics tools and applying several immune filters, a poly-epitope vaccine was constructed comprising cytotoxic T-cell lymphocyte (CTL)-, helper T-cell lymphocyte (HTL)-, and interferon-gamma (IFN-γ)-inducing epitopes. In addition, various physicochemical, allergenic, and antigenic profiles were evaluated to confirm the immunogenicity and safety of the vaccine. Molecular interactions, binding affinities, and the thermodynamic stability of the vaccine were examined through molecular docking and dynamic simulation approaches, during which we identified a stable and strong interaction with Toll-like receptors (TLRs). In silico immune simulations were performed to assess the immune-response triggering capabilities of the vaccine. This computational analysis suggested that the proposed vaccine candidate would be structurally stable and capable of generating an effective immune response to combat viral infections; however, experimental evaluations remain necessary to verify the exact safety and immunogenicity profile of this vaccine.Shafi MahmudMd. Oliullah RafiGobindo Kumar PaulMaria Meha PromiMst. Sharmin Sultana ShimuSuvro BiswasTalha Bin EmranKuldeep DhamaSalem A. AlyamiMohammad Ali MoniMd. Abu SalehNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-20 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shafi Mahmud
Md. Oliullah Rafi
Gobindo Kumar Paul
Maria Meha Promi
Mst. Sharmin Sultana Shimu
Suvro Biswas
Talha Bin Emran
Kuldeep Dhama
Salem A. Alyami
Mohammad Ali Moni
Md. Abu Saleh
Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach
description Abstract Currently, no approved vaccine is available against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes severe respiratory disease. The spike glycoprotein is typically considered a suitable target for MERS-CoV vaccine candidates. A computational strategy can be used to design an antigenic vaccine against a pathogen. Therefore, we used immunoinformatics and computational approaches to design a multi-epitope vaccine that targets the spike glycoprotein of MERS-CoV. After using numerous immunoinformatics tools and applying several immune filters, a poly-epitope vaccine was constructed comprising cytotoxic T-cell lymphocyte (CTL)-, helper T-cell lymphocyte (HTL)-, and interferon-gamma (IFN-γ)-inducing epitopes. In addition, various physicochemical, allergenic, and antigenic profiles were evaluated to confirm the immunogenicity and safety of the vaccine. Molecular interactions, binding affinities, and the thermodynamic stability of the vaccine were examined through molecular docking and dynamic simulation approaches, during which we identified a stable and strong interaction with Toll-like receptors (TLRs). In silico immune simulations were performed to assess the immune-response triggering capabilities of the vaccine. This computational analysis suggested that the proposed vaccine candidate would be structurally stable and capable of generating an effective immune response to combat viral infections; however, experimental evaluations remain necessary to verify the exact safety and immunogenicity profile of this vaccine.
format article
author Shafi Mahmud
Md. Oliullah Rafi
Gobindo Kumar Paul
Maria Meha Promi
Mst. Sharmin Sultana Shimu
Suvro Biswas
Talha Bin Emran
Kuldeep Dhama
Salem A. Alyami
Mohammad Ali Moni
Md. Abu Saleh
author_facet Shafi Mahmud
Md. Oliullah Rafi
Gobindo Kumar Paul
Maria Meha Promi
Mst. Sharmin Sultana Shimu
Suvro Biswas
Talha Bin Emran
Kuldeep Dhama
Salem A. Alyami
Mohammad Ali Moni
Md. Abu Saleh
author_sort Shafi Mahmud
title Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach
title_short Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach
title_full Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach
title_fullStr Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach
title_full_unstemmed Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach
title_sort designing a multi-epitope vaccine candidate to combat mers-cov by employing an immunoinformatics approach
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a7e3b9f2bf8947859cc3790916ca13fa
work_keys_str_mv AT shafimahmud designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
AT mdoliullahrafi designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
AT gobindokumarpaul designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
AT mariamehapromi designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
AT mstsharminsultanashimu designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
AT suvrobiswas designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
AT talhabinemran designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
AT kuldeepdhama designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
AT salemaalyami designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
AT mohammadalimoni designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
AT mdabusaleh designingamultiepitopevaccinecandidatetocombatmerscovbyemployinganimmunoinformaticsapproach
_version_ 1718383948052037632